Showing results (1781-1790 of 1,873) with videos related to

Sort By:
Pageof 188
Proteomics|November 25, 2011
Comprehensive proteomic analysis of human bileMustafa A Barbhuiya, Nandini A Sahasrabuddhe, Sneha M Pinto, et al.
Movement Disorders Clinical Practice|June 19, 2023
Genetic Movement Disorders Commonly Seen in AsiansPriya Jagota, Shen-Yang Lim, Pramod Kumar Pal, et al.
Frontiers in Microbiology|November 5, 2024
A rapid point-of-care population-scale dipstick assay to identify and differentiate SARS-CoV-2 variants in COVID-19-positive patientsDeepjyoti Paul, Jyoti Verma, Shakti Kumar, et al.
Journal of Movement Disorders|June 9, 2023
Historical and More Common Nongenetic Movement Disorders From AsiaNorlinah Mohamed Ibrahim, Priya Jagota, Pramod Kumar Pal, et al.
Drug Testing and Analysis|October 13, 2022
Process development for the total synthesis of the novel drug metabolite Carboxy toremifene as a standard reference material along with characterization and purity assessment for the Antidoping quality Control PurposesGangasani Jagadeesh Kumar, Sachin Dattram Pawar, Swati Ramesh Pawar, et al.
Journal of Medical Virology|August 22, 2024
Understanding the landscape of the SARS-CoV-2-specific T cells post-omicron surgeAkshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
Frontiers in Plant Science|October 10, 2022
Integrated management enhances crop physiology and final yield in maize intercropped with blackgram in semiarid South AsiaT Varatharajan, Anchal Dass, Anil K Choudhary, et al.
Clinical Neurophysiology Practice|July 28, 2022
Clinical neurophysiology of Parkinson's disease and parkinsonismRobert Chen, Alfredo Berardelli, Amitabh Bhattacharya, et al.
NPJ Parkinson'S Disease|April 15, 2024
Resequencing the complete SNCA locus in Indian patients with Parkinson's diseaseAsha Kishore, Marc Sturm, Kanchana Soman Pillai, et al.
Journal of Medicinal Chemistry|January 11, 2019
Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H<sub>3</sub> Receptor Inverse Agonist with Robust Wake-Promoting ActivityRamakrishna Nirogi, Anil Shinde, Abdul Rasheed Mohammed, et al.
Pageof 188